Vivani Medical, Inc.
Vivani Medical, Inc. (VANI) Stock Competitors & Peer Comparison
See (VANI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| VANI | $1.40 | +5.26% | 82.9M | -3.33 | -$0.42 | N/A |
| ABT | $129.93 | +2.08% | 226.2B | 16.31 | $7.97 | +1.79% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $106.79 | +1.31% | 158B | 63.55 | $1.68 | N/A |
| SYK | $381.49 | +0.98% | 145.8B | 50.47 | $7.56 | +0.87% |
| MDT | $89.64 | +0.34% | 114.8B | 24.82 | $3.61 | +3.15% |
| EW | $80.09 | +0.96% | 47B | 33.51 | $2.39 | N/A |
| DXCM | $76.25 | -3.82% | 29.9B | 53.70 | $1.42 | N/A |
| PHG | $26.72 | +0.98% | 25.4B | 148.36 | $0.18 | +3.33% |
| STE | $228.43 | +0.69% | 22.5B | 37.03 | $6.17 | +1.00% |
Stock Comparison
VANI vs ABT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ABT has a market cap of 226.2B. Regarding current trading prices, VANI is priced at $1.40, while ABT trades at $129.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ABT's P/E ratio is 16.31. In terms of profitability, VANI's ROE is -1.33%, compared to ABT's ROE of +0.32%. Regarding short-term risk, VANI is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ABT's competition here
VANI vs BSX-PA Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, VANI is priced at $1.40, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, VANI's ROE is -1.33%, compared to BSX-PA's ROE of +0.12%. Regarding short-term risk, VANI is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BSX-PA's competition here
VANI vs BSX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BSX has a market cap of 158B. Regarding current trading prices, VANI is priced at $1.40, while BSX trades at $106.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BSX's P/E ratio is 63.55. In terms of profitability, VANI's ROE is -1.33%, compared to BSX's ROE of +0.12%. Regarding short-term risk, VANI is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BSX's competition here
VANI vs SYK Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SYK has a market cap of 145.8B. Regarding current trading prices, VANI is priced at $1.40, while SYK trades at $381.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SYK's P/E ratio is 50.47. In terms of profitability, VANI's ROE is -1.33%, compared to SYK's ROE of +0.11%. Regarding short-term risk, VANI is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SYK's competition here
VANI vs MDT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, MDT has a market cap of 114.8B. Regarding current trading prices, VANI is priced at $1.40, while MDT trades at $89.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas MDT's P/E ratio is 24.82. In terms of profitability, VANI's ROE is -1.33%, compared to MDT's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check MDT's competition here
VANI vs EW Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, EW has a market cap of 47B. Regarding current trading prices, VANI is priced at $1.40, while EW trades at $80.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas EW's P/E ratio is 33.51. In terms of profitability, VANI's ROE is -1.33%, compared to EW's ROE of +0.45%. Regarding short-term risk, VANI is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check EW's competition here
VANI vs DXCM Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, DXCM has a market cap of 29.9B. Regarding current trading prices, VANI is priced at $1.40, while DXCM trades at $76.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas DXCM's P/E ratio is 53.70. In terms of profitability, VANI's ROE is -1.33%, compared to DXCM's ROE of +0.26%. Regarding short-term risk, VANI is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check DXCM's competition here
VANI vs PHG Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, PHG has a market cap of 25.4B. Regarding current trading prices, VANI is priced at $1.40, while PHG trades at $26.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas PHG's P/E ratio is 148.36. In terms of profitability, VANI's ROE is -1.33%, compared to PHG's ROE of +0.03%. Regarding short-term risk, VANI is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check PHG's competition here
VANI vs STE Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, STE has a market cap of 22.5B. Regarding current trading prices, VANI is priced at $1.40, while STE trades at $228.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas STE's P/E ratio is 37.03. In terms of profitability, VANI's ROE is -1.33%, compared to STE's ROE of +0.09%. Regarding short-term risk, VANI is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check STE's competition here
VANI vs PODD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, PODD has a market cap of 20.3B. Regarding current trading prices, VANI is priced at $1.40, while PODD trades at $287.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas PODD's P/E ratio is 51.76. In terms of profitability, VANI's ROE is -1.33%, compared to PODD's ROE of +0.35%. Regarding short-term risk, VANI is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check PODD's competition here
VANI vs ZBH Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ZBH has a market cap of 18.3B. Regarding current trading prices, VANI is priced at $1.40, while ZBH trades at $92.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ZBH's P/E ratio is 20.54. In terms of profitability, VANI's ROE is -1.33%, compared to ZBH's ROE of +0.07%. Regarding short-term risk, VANI is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ZBH's competition here
VANI vs ABMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, VANI is priced at $1.40, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ABMD's P/E ratio is 65.36. In terms of profitability, VANI's ROE is -1.33%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ABMD's competition here
VANI vs SNN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SNN has a market cap of 13.5B. Regarding current trading prices, VANI is priced at $1.40, while SNN trades at $30.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SNN's P/E ratio is 32.77. In terms of profitability, VANI's ROE is -1.33%, compared to SNN's ROE of +0.08%. Regarding short-term risk, VANI is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SNN's competition here
VANI vs SWAV Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, VANI is priced at $1.40, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SWAV's P/E ratio is 78.76. In terms of profitability, VANI's ROE is -1.33%, compared to SWAV's ROE of +0.14%. Regarding short-term risk, VANI is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SWAV's competition here
VANI vs ALGN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ALGN has a market cap of 10B. Regarding current trading prices, VANI is priced at $1.40, while ALGN trades at $137.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ALGN's P/E ratio is 23.27. In terms of profitability, VANI's ROE is -1.33%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, VANI is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ALGN's competition here
VANI vs PEN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, PEN has a market cap of 9.4B. Regarding current trading prices, VANI is priced at $1.40, while PEN trades at $240.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas PEN's P/E ratio is 63.41. In terms of profitability, VANI's ROE is -1.33%, compared to PEN's ROE of +0.12%. Regarding short-term risk, VANI is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check PEN's competition here
VANI vs BIO Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BIO has a market cap of 7.3B. Regarding current trading prices, VANI is priced at $1.40, while BIO trades at $276.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BIO's P/E ratio is 24.93. In terms of profitability, VANI's ROE is -1.33%, compared to BIO's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BIO's competition here
VANI vs GMED Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, GMED has a market cap of 7.3B. Regarding current trading prices, VANI is priced at $1.40, while GMED trades at $53.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas GMED's P/E ratio is 40.04. In terms of profitability, VANI's ROE is -1.33%, compared to GMED's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check GMED's competition here
VANI vs BIO-B Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BIO-B has a market cap of 6.8B. Regarding current trading prices, VANI is priced at $1.40, while BIO-B trades at $247.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BIO-B's P/E ratio is -3.23. In terms of profitability, VANI's ROE is -1.33%, compared to BIO-B's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BIO-B's competition here
VANI vs IRTC Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, IRTC has a market cap of 5.3B. Regarding current trading prices, VANI is priced at $1.40, while IRTC trades at $164.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas IRTC's P/E ratio is -52.73. In terms of profitability, VANI's ROE is -1.33%, compared to IRTC's ROE of -1.05%. Regarding short-term risk, VANI is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check IRTC's competition here
VANI vs BRKR Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BRKR has a market cap of 5.3B. Regarding current trading prices, VANI is priced at $1.40, while BRKR trades at $34.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BRKR's P/E ratio is 66.76. In terms of profitability, VANI's ROE is -1.33%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, VANI is less volatile compared to BRKR. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check BRKR's competition here
VANI vs GKOS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, GKOS has a market cap of 5B. Regarding current trading prices, VANI is priced at $1.40, while GKOS trades at $87.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas GKOS's P/E ratio is -54.34. In terms of profitability, VANI's ROE is -1.33%, compared to GKOS's ROE of -0.13%. Regarding short-term risk, VANI is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check GKOS's competition here
VANI vs NARI Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, VANI is priced at $1.40, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas NARI's P/E ratio is -59.24. In terms of profitability, VANI's ROE is -1.33%, compared to NARI's ROE of -0.18%. Regarding short-term risk, VANI is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check NARI's competition here
VANI vs TMDX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, TMDX has a market cap of 4.4B. Regarding current trading prices, VANI is priced at $1.40, while TMDX trades at $128.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas TMDX's P/E ratio is 64.57. In terms of profitability, VANI's ROE is -1.33%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, VANI is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check TMDX's competition here
VANI vs INSP Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, INSP has a market cap of 3.8B. Regarding current trading prices, VANI is priced at $1.40, while INSP trades at $129.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas INSP's P/E ratio is 59.54. In terms of profitability, VANI's ROE is -1.33%, compared to INSP's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to INSP. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check INSP's competition here
VANI vs ITGR Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ITGR has a market cap of 3.7B. Regarding current trading prices, VANI is priced at $1.40, while ITGR trades at $106.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ITGR's P/E ratio is 45.68. In terms of profitability, VANI's ROE is -1.33%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ITGR's competition here
VANI vs AXNX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, VANI is priced at $1.40, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas AXNX's P/E ratio is -709.80. In terms of profitability, VANI's ROE is -1.33%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, VANI is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check AXNX's competition here
VANI vs PRCT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, PRCT has a market cap of 2.7B. Regarding current trading prices, VANI is priced at $1.40, while PRCT trades at $49.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas PRCT's P/E ratio is -29.35. In terms of profitability, VANI's ROE is -1.33%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, VANI is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check PRCT's competition here
VANI vs LIVN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, LIVN has a market cap of 2.3B. Regarding current trading prices, VANI is priced at $1.40, while LIVN trades at $42.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas LIVN's P/E ratio is -10.51. In terms of profitability, VANI's ROE is -1.33%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, VANI is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check LIVN's competition here
VANI vs ATEC Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ATEC has a market cap of 2.2B. Regarding current trading prices, VANI is priced at $1.40, while ATEC trades at $14.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ATEC's P/E ratio is -13.16. In terms of profitability, VANI's ROE is -1.33%, compared to ATEC's ROE of -2.77%. Regarding short-term risk, VANI is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ATEC's competition here
VANI vs NUVA Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, VANI is priced at $1.40, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas NUVA's P/E ratio is 75.00. In terms of profitability, VANI's ROE is -1.33%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, VANI is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check NUVA's competition here
VANI vs UFPT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, UFPT has a market cap of 1.7B. Regarding current trading prices, VANI is priced at $1.40, while UFPT trades at $226.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas UFPT's P/E ratio is 27.73. In terms of profitability, VANI's ROE is -1.33%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, VANI is more volatile compared to UFPT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check UFPT's competition here
VANI vs CNMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CNMD has a market cap of 1.7B. Regarding current trading prices, VANI is priced at $1.40, while CNMD trades at $53.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CNMD's P/E ratio is 15.12. In terms of profitability, VANI's ROE is -1.33%, compared to CNMD's ROE of +0.11%. Regarding short-term risk, VANI is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CNMD's competition here
VANI vs AORT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, VANI is priced at $1.40, while AORT trades at $32.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas AORT's P/E ratio is -62.88. In terms of profitability, VANI's ROE is -1.33%, compared to AORT's ROE of -0.07%. Regarding short-term risk, VANI is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check AORT's competition here
VANI vs HSKA Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, VANI is priced at $1.40, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas HSKA's P/E ratio is -62.49. In terms of profitability, VANI's ROE is -1.33%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, VANI is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check HSKA's competition here
VANI vs SSII Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SSII has a market cap of 1.3B. Regarding current trading prices, VANI is priced at $1.40, while SSII trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SSII's P/E ratio is -80.75. In terms of profitability, VANI's ROE is -1.33%, compared to SSII's ROE of -1.05%. Regarding short-term risk, VANI is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check SSII's competition here
VANI vs ESTA Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ESTA has a market cap of 1.2B. Regarding current trading prices, VANI is priced at $1.40, while ESTA trades at $42.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ESTA's P/E ratio is -13.69. In terms of profitability, VANI's ROE is -1.33%, compared to ESTA's ROE of -2.10%. Regarding short-term risk, VANI is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ESTA's competition here
VANI vs AHCO Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, AHCO has a market cap of 1.2B. Regarding current trading prices, VANI is priced at $1.40, while AHCO trades at $9.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas AHCO's P/E ratio is 15.73. In terms of profitability, VANI's ROE is -1.33%, compared to AHCO's ROE of +0.06%. Regarding short-term risk, VANI is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check AHCO's competition here
VANI vs SILK Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, VANI is priced at $1.40, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SILK's P/E ratio is -18.96. In terms of profitability, VANI's ROE is -1.33%, compared to SILK's ROE of -0.29%. Regarding short-term risk, VANI is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SILK's competition here
VANI vs FNA Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, VANI is priced at $1.40, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas FNA's P/E ratio is -19.83. In terms of profitability, VANI's ROE is -1.33%, compared to FNA's ROE of -0.36%. Regarding short-term risk, VANI is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check FNA's competition here
VANI vs TNDM Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, TNDM has a market cap of 1B. Regarding current trading prices, VANI is priced at $1.40, while TNDM trades at $15.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas TNDM's P/E ratio is -5.53. In terms of profitability, VANI's ROE is -1.33%, compared to TNDM's ROE of -0.83%. Regarding short-term risk, VANI is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check TNDM's competition here
VANI vs IART Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, IART has a market cap of 978.6M. Regarding current trading prices, VANI is priced at $1.40, while IART trades at $12.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas IART's P/E ratio is -1.92. In terms of profitability, VANI's ROE is -1.33%, compared to IART's ROE of -0.44%. Regarding short-term risk, VANI is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check IART's competition here
VANI vs INMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, INMD has a market cap of 978.3M. Regarding current trading prices, VANI is priced at $1.40, while INMD trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas INMD's P/E ratio is 5.91. In terms of profitability, VANI's ROE is -1.33%, compared to INMD's ROE of +0.27%. Regarding short-term risk, VANI is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check INMD's competition here
VANI vs IRMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, IRMD has a market cap of 898.8M. Regarding current trading prices, VANI is priced at $1.40, while IRMD trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas IRMD's P/E ratio is 45.61. In terms of profitability, VANI's ROE is -1.33%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, VANI is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check IRMD's competition here
VANI vs CSII Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, VANI is priced at $1.40, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CSII's P/E ratio is -20.83. In terms of profitability, VANI's ROE is -1.33%, compared to CSII's ROE of -0.14%. Regarding short-term risk, VANI is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CSII's competition here
VANI vs SMLR Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SMLR has a market cap of 820.1M. Regarding current trading prices, VANI is priced at $1.40, while SMLR trades at $35.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SMLR's P/E ratio is -14.80. In terms of profitability, VANI's ROE is -1.33%, compared to SMLR's ROE of -0.21%. Regarding short-term risk, VANI is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SMLR's competition here
VANI vs SIBN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SIBN has a market cap of 762.8M. Regarding current trading prices, VANI is priced at $1.40, while SIBN trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SIBN's P/E ratio is -28.41. In terms of profitability, VANI's ROE is -1.33%, compared to SIBN's ROE of -0.16%. Regarding short-term risk, VANI is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SIBN's competition here
VANI vs CRY Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, VANI is priced at $1.40, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CRY's P/E ratio is 425.71. In terms of profitability, VANI's ROE is -1.33%, compared to CRY's ROE of -0.07%. Regarding short-term risk, VANI is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CRY's competition here
VANI vs APEN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, VANI is priced at $1.40, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas APEN's P/E ratio is -9.43. In terms of profitability, VANI's ROE is -1.33%, compared to APEN's ROE of -0.85%. Regarding short-term risk, VANI is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check APEN's competition here
VANI vs AXGN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, AXGN has a market cap of 571.6M. Regarding current trading prices, VANI is priced at $1.40, while AXGN trades at $12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas AXGN's P/E ratio is -78.44. In terms of profitability, VANI's ROE is -1.33%, compared to AXGN's ROE of -0.07%. Regarding short-term risk, VANI is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check AXGN's competition here
VANI vs CBLL Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CBLL has a market cap of 550.5M. Regarding current trading prices, VANI is priced at $1.40, while CBLL trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CBLL's P/E ratio is -12.28. In terms of profitability, VANI's ROE is -1.33%, compared to CBLL's ROE of -1.64%. Regarding short-term risk, VANI is more volatile compared to CBLL. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CBLL's competition here
VANI vs ZIMV Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ZIMV has a market cap of 529.8M. Regarding current trading prices, VANI is priced at $1.40, while ZIMV trades at $18.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ZIMV's P/E ratio is -27.23. In terms of profitability, VANI's ROE is -1.33%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, VANI is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ZIMV's competition here
VANI vs AVNS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, AVNS has a market cap of 522.1M. Regarding current trading prices, VANI is priced at $1.40, while AVNS trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas AVNS's P/E ratio is -1.37. In terms of profitability, VANI's ROE is -1.33%, compared to AVNS's ROE of -0.37%. Regarding short-term risk, VANI is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check AVNS's competition here
VANI vs SRDX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SRDX has a market cap of 509.5M. Regarding current trading prices, VANI is priced at $1.40, while SRDX trades at $35.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SRDX's P/E ratio is -25.45. In terms of profitability, VANI's ROE is -1.33%, compared to SRDX's ROE of -0.17%. Regarding short-term risk, VANI is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SRDX's competition here
VANI vs KIDS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, KIDS has a market cap of 508.5M. Regarding current trading prices, VANI is priced at $1.40, while KIDS trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas KIDS's P/E ratio is -11.66. In terms of profitability, VANI's ROE is -1.33%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, VANI is more volatile compared to KIDS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check KIDS's competition here
VANI vs CTKB Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CTKB has a market cap of 486.4M. Regarding current trading prices, VANI is priced at $1.40, while CTKB trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CTKB's P/E ratio is -42.67. In terms of profitability, VANI's ROE is -1.33%, compared to CTKB's ROE of -0.03%. Regarding short-term risk, VANI is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CTKB's competition here
VANI vs BFLY-WT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BFLY-WT has a market cap of 479.7M. Regarding current trading prices, VANI is priced at $1.40, while BFLY-WT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, VANI's ROE is -1.33%, compared to BFLY-WT's ROE of -0.31%. Regarding short-term risk, VANI is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check BFLY-WT's competition here
VANI vs OFIX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, OFIX has a market cap of 425.1M. Regarding current trading prices, VANI is priced at $1.40, while OFIX trades at $10.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas OFIX's P/E ratio is -2.93. In terms of profitability, VANI's ROE is -1.33%, compared to OFIX's ROE of -0.28%. Regarding short-term risk, VANI is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check OFIX's competition here
VANI vs BVS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BVS has a market cap of 419.4M. Regarding current trading prices, VANI is priced at $1.40, while BVS trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BVS's P/E ratio is -13.17. In terms of profitability, VANI's ROE is -1.33%, compared to BVS's ROE of -0.21%. Regarding short-term risk, VANI is more volatile compared to BVS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BVS's competition here
VANI vs PACB Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, PACB has a market cap of 417.1M. Regarding current trading prices, VANI is priced at $1.40, while PACB trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas PACB's P/E ratio is -0.51. In terms of profitability, VANI's ROE is -1.33%, compared to PACB's ROE of -1.70%. Regarding short-term risk, VANI is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check PACB's competition here
VANI vs SENS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SENS has a market cap of 382.2M. Regarding current trading prices, VANI is priced at $1.40, while SENS trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SENS's P/E ratio is -4.61. In terms of profitability, VANI's ROE is -1.33%, compared to SENS's ROE of -7.46%. Regarding short-term risk, VANI is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SENS's competition here
VANI vs TMCI Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, TMCI has a market cap of 352.9M. Regarding current trading prices, VANI is priced at $1.40, while TMCI trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas TMCI's P/E ratio is -6.60. In terms of profitability, VANI's ROE is -1.33%, compared to TMCI's ROE of -0.49%. Regarding short-term risk, VANI is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check TMCI's competition here
VANI vs BFLY Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BFLY has a market cap of 352.4M. Regarding current trading prices, VANI is priced at $1.40, while BFLY trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BFLY's P/E ratio is -4.75. In terms of profitability, VANI's ROE is -1.33%, compared to BFLY's ROE of -0.31%. Regarding short-term risk, VANI is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BFLY's competition here
VANI vs RXST Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, RXST has a market cap of 321.8M. Regarding current trading prices, VANI is priced at $1.40, while RXST trades at $7.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas RXST's P/E ratio is -12.00. In terms of profitability, VANI's ROE is -1.33%, compared to RXST's ROE of -0.10%. Regarding short-term risk, VANI is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check RXST's competition here
VANI vs SNWV Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SNWV has a market cap of 304.1M. Regarding current trading prices, VANI is priced at $1.40, while SNWV trades at $35.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SNWV's P/E ratio is -5.70. In terms of profitability, VANI's ROE is -1.33%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, VANI is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SNWV's competition here
VANI vs NNOX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, NNOX has a market cap of 302.9M. Regarding current trading prices, VANI is priced at $1.40, while NNOX trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas NNOX's P/E ratio is -5.22. In terms of profitability, VANI's ROE is -1.33%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, VANI is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check NNOX's competition here
VANI vs CLPT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CLPT has a market cap of 297.1M. Regarding current trading prices, VANI is priced at $1.40, while CLPT trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CLPT's P/E ratio is -13.83. In terms of profitability, VANI's ROE is -1.33%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, VANI is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CLPT's competition here
VANI vs VREX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, VREX has a market cap of 295.1M. Regarding current trading prices, VANI is priced at $1.40, while VREX trades at $7.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas VREX's P/E ratio is -6.90. In terms of profitability, VANI's ROE is -1.33%, compared to VREX's ROE of -0.08%. Regarding short-term risk, VANI is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check VREX's competition here
VANI vs NPCE Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, NPCE has a market cap of 292.9M. Regarding current trading prices, VANI is priced at $1.40, while NPCE trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas NPCE's P/E ratio is -10.89. In terms of profitability, VANI's ROE is -1.33%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, VANI is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check NPCE's competition here
VANI vs CATX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CATX has a market cap of 288M. Regarding current trading prices, VANI is priced at $1.40, while CATX trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CATX's P/E ratio is -3.15. In terms of profitability, VANI's ROE is -1.33%, compared to CATX's ROE of -0.27%. Regarding short-term risk, VANI is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CATX's competition here
VANI vs QTRX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, QTRX has a market cap of 281.8M. Regarding current trading prices, VANI is priced at $1.40, while QTRX trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas QTRX's P/E ratio is -4.87. In terms of profitability, VANI's ROE is -1.33%, compared to QTRX's ROE of -0.15%. Regarding short-term risk, VANI is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check QTRX's competition here
VANI vs OM Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, OM has a market cap of 250.9M. Regarding current trading prices, VANI is priced at $1.40, while OM trades at $14.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas OM's P/E ratio is -0.49. In terms of profitability, VANI's ROE is -1.33%, compared to OM's ROE of -1.45%. Regarding short-term risk, VANI is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check OM's competition here
VANI vs CERS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CERS has a market cap of 248.5M. Regarding current trading prices, VANI is priced at $1.40, while CERS trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CERS's P/E ratio is -13.00. In terms of profitability, VANI's ROE is -1.33%, compared to CERS's ROE of -0.35%. Regarding short-term risk, VANI is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CERS's competition here
VANI vs VMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, VMD has a market cap of 239.9M. Regarding current trading prices, VANI is priced at $1.40, while VMD trades at $6.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas VMD's P/E ratio is 20.23. In terms of profitability, VANI's ROE is -1.33%, compared to VMD's ROE of +0.10%. Regarding short-term risk, VANI is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check VMD's competition here
VANI vs MASS Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, MASS has a market cap of 233.8M. Regarding current trading prices, VANI is priced at $1.40, while MASS trades at $6.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas MASS's P/E ratio is -2.94. In terms of profitability, VANI's ROE is -1.33%, compared to MASS's ROE of -0.13%. Regarding short-term risk, VANI is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check MASS's competition here
VANI vs TCMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, TCMD has a market cap of 229.9M. Regarding current trading prices, VANI is priced at $1.40, while TCMD trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas TCMD's P/E ratio is 14.98. In terms of profitability, VANI's ROE is -1.33%, compared to TCMD's ROE of +0.08%. Regarding short-term risk, VANI is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check TCMD's competition here
VANI vs NVRO Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, VANI is priced at $1.40, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas NVRO's P/E ratio is -1.91. In terms of profitability, VANI's ROE is -1.33%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, VANI is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check NVRO's competition here
VANI vs MXCT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, MXCT has a market cap of 221.1M. Regarding current trading prices, VANI is priced at $1.40, while MXCT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas MXCT's P/E ratio is -5.20. In terms of profitability, VANI's ROE is -1.33%, compared to MXCT's ROE of -0.20%. Regarding short-term risk, VANI is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check MXCT's competition here
VANI vs BWAY Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BWAY has a market cap of 221.1M. Regarding current trading prices, VANI is priced at $1.40, while BWAY trades at $11.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BWAY's P/E ratio is 53.18. In terms of profitability, VANI's ROE is -1.33%, compared to BWAY's ROE of +0.07%. Regarding short-term risk, VANI is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BWAY's competition here
VANI vs EYES Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, VANI is priced at $1.40, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas EYES's P/E ratio is N/A. In terms of profitability, VANI's ROE is -1.33%, compared to EYES's ROE of -0.26%. Regarding short-term risk, VANI is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check EYES's competition here
VANI vs MGRM Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, MGRM has a market cap of 197.8M. Regarding current trading prices, VANI is priced at $1.40, while MGRM trades at $5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas MGRM's P/E ratio is -10.94. In terms of profitability, VANI's ROE is -1.33%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, VANI is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check MGRM's competition here
VANI vs CVRX Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, CVRX has a market cap of 196.8M. Regarding current trading prices, VANI is priced at $1.40, while CVRX trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas CVRX's P/E ratio is -3.53. In terms of profitability, VANI's ROE is -1.33%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, VANI is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check CVRX's competition here
VANI vs SGHT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, SGHT has a market cap of 179.4M. Regarding current trading prices, VANI is priced at $1.40, while SGHT trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas SGHT's P/E ratio is -3.54. In terms of profitability, VANI's ROE is -1.33%, compared to SGHT's ROE of -0.55%. Regarding short-term risk, VANI is more volatile compared to SGHT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check SGHT's competition here
VANI vs INGN Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, INGN has a market cap of 175.8M. Regarding current trading prices, VANI is priced at $1.40, while INGN trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas INGN's P/E ratio is -5.69. In terms of profitability, VANI's ROE is -1.33%, compared to INGN's ROE of -0.15%. Regarding short-term risk, VANI is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check INGN's competition here
VANI vs PROF Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, PROF has a market cap of 169.3M. Regarding current trading prices, VANI is priced at $1.40, while PROF trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas PROF's P/E ratio is -4.66. In terms of profitability, VANI's ROE is -1.33%, compared to PROF's ROE of -0.70%. Regarding short-term risk, VANI is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check PROF's competition here
VANI vs TLSI Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, TLSI has a market cap of 159.9M. Regarding current trading prices, VANI is priced at $1.40, while TLSI trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas TLSI's P/E ratio is -3.83. In terms of profitability, VANI's ROE is -1.33%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, VANI is more volatile compared to TLSI. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check TLSI's competition here
VANI vs ELMD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ELMD has a market cap of 156.2M. Regarding current trading prices, VANI is priced at $1.40, while ELMD trades at $18.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ELMD's P/E ratio is 23.58. In terms of profitability, VANI's ROE is -1.33%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, VANI is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ELMD's competition here
VANI vs LNSR Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, LNSR has a market cap of 154.3M. Regarding current trading prices, VANI is priced at $1.40, while LNSR trades at $12.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas LNSR's P/E ratio is -2.67. In terms of profitability, VANI's ROE is -1.33%, compared to LNSR's ROE of -5.28%. Regarding short-term risk, VANI is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check LNSR's competition here
VANI vs RPID Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, RPID has a market cap of 153M. Regarding current trading prices, VANI is priced at $1.40, while RPID trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas RPID's P/E ratio is -3.39. In terms of profitability, VANI's ROE is -1.33%, compared to RPID's ROE of -0.56%. Regarding short-term risk, VANI is less volatile compared to RPID. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check RPID's competition here
VANI vs RCEL Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, RCEL has a market cap of 141.7M. Regarding current trading prices, VANI is priced at $1.40, while RCEL trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas RCEL's P/E ratio is -2.45. In terms of profitability, VANI's ROE is -1.33%, compared to RCEL's ROE of -3.38%. Regarding short-term risk, VANI is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check RCEL's competition here
VANI vs BSGM Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, BSGM has a market cap of 138.8M. Regarding current trading prices, VANI is priced at $1.40, while BSGM trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas BSGM's P/E ratio is -8.36. In terms of profitability, VANI's ROE is -1.33%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, VANI is more volatile compared to BSGM. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check BSGM's competition here
VANI vs AVR Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, AVR has a market cap of 127.5M. Regarding current trading prices, VANI is priced at $1.40, while AVR trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas AVR's P/E ratio is -0.99. In terms of profitability, VANI's ROE is -1.33%, compared to AVR's ROE of -2.92%. Regarding short-term risk, VANI is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check AVR's competition here
VANI vs ANIK Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ANIK has a market cap of 126.4M. Regarding current trading prices, VANI is priced at $1.40, while ANIK trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ANIK's P/E ratio is -9.74. In terms of profitability, VANI's ROE is -1.33%, compared to ANIK's ROE of -0.35%. Regarding short-term risk, VANI is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ANIK's competition here
VANI vs OWLT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, OWLT has a market cap of 121.6M. Regarding current trading prices, VANI is priced at $1.40, while OWLT trades at $7.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas OWLT's P/E ratio is -4.57. In terms of profitability, VANI's ROE is -1.33%, compared to OWLT's ROE of +1.25%. Regarding short-term risk, VANI is less volatile compared to OWLT. This indicates potentially lower risk in terms of short-term price fluctuations for VANI.Check OWLT's competition here
VANI vs LUCD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, LUCD has a market cap of 110.4M. Regarding current trading prices, VANI is priced at $1.40, while LUCD trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas LUCD's P/E ratio is -0.87. In terms of profitability, VANI's ROE is -1.33%, compared to LUCD's ROE of +26.96%. Regarding short-term risk, VANI is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check LUCD's competition here
VANI vs ICAD Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, VANI is priced at $1.40, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas ICAD's P/E ratio is -20.37. In terms of profitability, VANI's ROE is -1.33%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, VANI is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check ICAD's competition here
VANI vs QIPT Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, QIPT has a market cap of 104.7M. Regarding current trading prices, VANI is priced at $1.40, while QIPT trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas QIPT's P/E ratio is -11.48. In terms of profitability, VANI's ROE is -1.33%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, VANI is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check QIPT's competition here
VANI vs HJLI Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, VANI is priced at $1.40, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas HJLI's P/E ratio is N/A. In terms of profitability, VANI's ROE is -1.33%, compared to HJLI's ROE of -0.57%. Regarding short-term risk, VANI is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check HJLI's competition here
VANI vs FONR Comparison August 2025
VANI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, VANI stands at 82.9M. In comparison, FONR has a market cap of 95.3M. Regarding current trading prices, VANI is priced at $1.40, while FONR trades at $15.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
VANI currently has a P/E ratio of -3.33, whereas FONR's P/E ratio is 12.29. In terms of profitability, VANI's ROE is -1.33%, compared to FONR's ROE of +0.09%. Regarding short-term risk, VANI is more volatile compared to FONR. This indicates potentially higher risk in terms of short-term price fluctuations for VANI.Check FONR's competition here